Cantor Fitzgerald Reiterates Overweight on Clene, Maintains $4 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Clene (NASDAQ:CLNN) and maintained a $4 price target.

August 16, 2023 | 1:31 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on Clene, maintaining a $4 price target. This could potentially influence investor sentiment.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates their positive outlook on Clene. However, as the price target is maintained, it suggests no new significant changes in the company's valuation. This could potentially influence investor sentiment but may not have a direct immediate impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100